# Corcept Presents New Data at ADA: Improved Outcomes in Patients Receiving a GLP-1 with Difficult-to-Control Type 2 Diabetes and Hypercortisolism Treated with Korlym®

- URL: https://theranews.net/blog/2026-06-07-corcept-presents-new-data-at-ada-improved-outcomes-in-patients-receiving-a-glp-1-991a7d/
- Published: 2026-06-07
- Type: Archive summary (AI-assisted summary of third-party reporting)
- Original outlet: financialcontent
- Original report: https://www.financialcontent.com/article/bizwire-2026-6-6-corcept-presents-new-data-at-ada-improved-outcomes-in-patients-receiving-a-glp-1-with-difficult-to-control-type-2-diabetes-and-hypercortisolism-treated-with-korlym
- Topics: anxiety
- Publisher: TheraNews, operated by AdvancedCare USA Inc.
- Notice: Educational content, not medical, legal, billing or financial advice. Cite the original outlet, not this summary.

> Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced the presentation of ne

---
![Corcept Presents New Data at ADA: Improved Outcomes in Patients Receiving a GLP-1 with Difficult-to-Control Type 2 Diabetes and Hypercortisolism Treated with Korlym®](/uploads/news-images/corcept-presents-new-data-at-ada-improved-outcome-20260607110042.jpeg)

---
*Originally reported by financialcontent. [Read more](https://www.financialcontent.com/article/bizwire-2026-6-6-corcept-presents-new-data-at-ada-improved-outcomes-in-patients-receiving-a-glp-1-with-difficult-to-control-type-2-diabetes-and-hypercortisolism-treated-with-korlym)*

---

*Source: [https://www.financialcontent.com/article/bizwire-2026-6-6-corcept-presents-new-data-at-ada-improved-outcomes-in-patients-receiving-a-glp-1-with-difficult-to-control-type-2-diabetes-and-hypercortisolism-treated-with-korlym](https://www.financialcontent.com/article/bizwire-2026-6-6-corcept-presents-new-data-at-ada-improved-outcomes-in-patients-receiving-a-glp-1-with-difficult-to-control-type-2-diabetes-and-hypercortisolism-treated-with-korlym)*